This post was also written by Ruth N. Holzman and Angelo Ciavarella.
On May 2, 2011, the Internal Revenue Service (the “IRS”) issued Revenue Procedure 2011-24 (the “Revenue Procedure”), which establishes a dispute resolution process for the preliminary fee calculation for the 2011 fee imposed on certain manufacturers and importers of branded prescription drugs pursuant